Publicacións nas que colabora con José Ramón González Juanatey (64)

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

2022

  1. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

  2. Real-life effect on the control of risk factors associated with initiation of the cardiovascular polypill created from equipotent drugs

    Revista Clinica Espanola, Vol. 222, Núm. 3, pp. 131-137

2020

  1. Development and validation of a clinical score to estimate progression to severe or critical state in COVID-19 pneumonia hospitalized patients

    Scientific Reports, Vol. 10, Núm. 1

  2. Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770

2018

  1. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529

2017

  1. Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure

    International Journal of Cardiology, Vol. 230, pp. 108-114

2016

  1. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

    QJM, Vol. 109, Núm. 6, pp. 377-382

2015

  1. Systemic sclerosis: A rare cause of heart failure?

    Revista Portuguesa de Cardiologia, Vol. 34, Núm. 10, pp. 617.e1-617.e5

2014

  1. Contrast-induced nephropathy and bleeding: A bidirectional link with prognostic value in acute coronary syndrome

    International Journal of Cardiology, Vol. 176, Núm. 1, pp. 235-236

2013

  1. Cambios electrocardiográficos durante la prueba de esfuerzo en un paciente con patrón electrocardiográfico tipo 1 de Brugada: Una curiosidad con implicaciones clínicas

    Revista Espanola de Anestesiologia y Reanimacion

  2. GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function

    Angiology, Vol. 64, Núm. 1, pp. 31-39

  3. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 117-122

  4. Prognostic influence of prior ischemic heart disease in in-hospital mortality of acute coronary syndromes

    International Journal of Cardiology, Vol. 168, Núm. 5, pp. 5063-5064

2012

  1. Advanced glycation end products: A mysterious shadow beyond the relationship between HbA1c and atrial fibrillation

    International Journal of Cardiology, Vol. 157, Núm. 3, pp. 441

  2. Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome

    European Heart Journal: Acute Cardiovascular Care, Vol. 1, Núm. 3, pp. 222-231

  3. Is glycated hemoglobin an accurate enough predictor of subclinical myocardial injury or a simple precursor of advanced glycation end products?

    Journal of the American College of Cardiology

  4. Protocolos de actuación en el Área Neurovascular. Xerencia de Xestión Integrada de Santiago de Compostela

    Conselleria de Sanidade

  5. Walking beyond the GRACE (Global Registry of Acute Coronary Events) model in the death risk stratification during hospitalization in patients with acute coronary syndrome: What do the AR-G (ACTION [Acute Coronary Treatment and Intervention Outcomes Network] registry and GWTG [Get with the Guidelines] Database), NCDR (National Cardiovascular Data Registry), and EuroHeart risk scores provide?

    JACC: Cardiovascular Interventions, Vol. 5, Núm. 11, pp. 1117-1125

2011

  1. Diagnostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Pleural Effusions of Cardiac Origin

    Archivos de Bronconeumologia, Vol. 47, Núm. 5, pp. 246-251